Jump to section
IdentificationPharmacologyInteractionsReferencesTrialsEconomicsPropertiesSpectraTaxonomyThiamphenicol
Identification
- Name
- Thiamphenicol
- Accession Number
- DB08621
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Description
- Not Available
- Structure
- Synonyms
- Not Available
- Categories
- UNII
- FLQ7571NPM
- CAS number
- 15318-45-3
- Weight
- Average: 356.222
Monoisotopic: 355.004798699 - Chemical Formula
- C12H15Cl2NO5S
- InChI Key
- OTVAEFIXJLOWRX-NXEZZACHSA-N
- InChI
- InChI=1S/C12H15Cl2NO5S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-16)15-12(18)11(13)14/h2-5,9-11,16-17H,6H2,1H3,(H,15,18)/t9-,10-/m1/s1
- IUPAC Name
- 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methanesulfonylphenyl)propan-2-yl]acetamide
- SMILES
- [H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(C=C1)S(C)(=O)=O
Pharmacology
- Indication
- Not Available
- Pharmacodynamics
- Not Available
- Mechanism of action
Target Actions Organism UDr hemagglutinin structural subunit Not Available Escherichia coli - Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half life
- Not Available
- Clearance
- Not Available
- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
Drug Interaction (R)-warfarin The risk or severity of bleeding can be increased when Thiamphenicol is combined with (R)-warfarin. (S)-Warfarin The risk or severity of bleeding can be increased when Thiamphenicol is combined with (S)-Warfarin. 4-hydroxycoumarin The risk or severity of bleeding can be increased when Thiamphenicol is combined with 4-hydroxycoumarin. Acenocoumarol The risk or severity of bleeding can be increased when Thiamphenicol is combined with Acenocoumarol. Adenovirus type 7 vaccine live The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Thiamphenicol. Anthrax immune globulin human The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Thiamphenicol. Anthrax vaccine The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Thiamphenicol. Bacillus calmette-guerin substrain connaught live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Thiamphenicol. Bacillus calmette-guerin substrain danish 1331 live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain danish 1331 live antigen can be decreased when used in combination with Thiamphenicol. Bacillus calmette-guerin substrain tice live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Thiamphenicol. - Food Interactions
- Not Available
References
- Synthesis Reference
Franco Pozzi, Claudia Tortora, Angelo Carenzi, "Pharmaceutical preparation containing thiamphenicol for veterinary use." U.S. Patent US4912138, issued January, 1979.
US4912138- General References
- Not Available
- External Links
- KEGG Compound
- C12853
- PubChem Compound
- 27200
- PubChem Substance
- 99445092
- ChemSpider
- 25315
- BindingDB
- 58925
- ChEBI
- 32215
- ChEMBL
- CHEMBL1236282
- HET
- TH8
- Wikipedia
- Thiamphenicol
- ATC Codes
- J01BA02 — Thiamphenicol
- J01BA — Amphenicols
- J01B — AMPHENICOLS
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE
- J — ANTIINFECTIVES FOR SYSTEMIC USE
- PDB Entries
- 2jkj
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1 Completed Basic Science Healthy Volunteers 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 2.27 mg/mL ALOGPS logP 0.33 ALOGPS logP -0.22 ChemAxon logS -2.2 ALOGPS pKa (Strongest Acidic) 7.65 ChemAxon pKa (Strongest Basic) -2.8 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 5 ChemAxon Hydrogen Donor Count 3 ChemAxon Polar Surface Area 103.7 Å2 ChemAxon Rotatable Bond Count 6 ChemAxon Refractivity 79.88 m3·mol-1 ChemAxon Polarizability 32.29 Å3 ChemAxon Number of Rings 1 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter Yes ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET features
Property Value Probability Human Intestinal Absorption + 0.931 Blood Brain Barrier + 0.9383 Caco-2 permeable - 0.61 P-glycoprotein substrate Non-substrate 0.7574 P-glycoprotein inhibitor I Non-inhibitor 0.9489 P-glycoprotein inhibitor II Non-inhibitor 0.9432 Renal organic cation transporter Non-inhibitor 0.9236 CYP450 2C9 substrate Non-substrate 0.5856 CYP450 2D6 substrate Non-substrate 0.8164 CYP450 3A4 substrate Non-substrate 0.5896 CYP450 1A2 substrate Non-inhibitor 0.9045 CYP450 2C9 inhibitor Non-inhibitor 0.9071 CYP450 2D6 inhibitor Non-inhibitor 0.9231 CYP450 2C19 inhibitor Non-inhibitor 0.9025 CYP450 3A4 inhibitor Non-inhibitor 0.831 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8529 Ames test Non AMES toxic 0.7181 Carcinogenicity Non-carcinogens 0.6535 Biodegradation Ready biodegradable 0.706 Rat acute toxicity 2.2718 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9972 hERG inhibition (predictor II) Non-inhibitor 0.9289
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available LC-MS/MS Spectrum - LC-ESI-qTof , Positive LC-MS/MS Not Available LC-MS/MS Spectrum - LC-ESI-qTof , Positive LC-MS/MS Not Available MS/MS Spectrum - , positive LC-MS/MS splash10-0a4i-0649000000-3f7e62d09a29a445c8a6 MS/MS Spectrum - , positive LC-MS/MS splash10-0002-2931000000-1f1691e17ae627c7d762
Taxonomy
- Description
- This compound belongs to the class of organic compounds known as benzenesulfonyl compounds. These are aromatic compounds containing a benzenesulfonyl group, which consists of a monocyclic benzene moiety that carries a sulfonyl group.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Benzenesulfonyl compounds
- Direct Parent
- Benzenesulfonyl compounds
- Alternative Parents
- Sulfones / Secondary carboxylic acid amides / Secondary alcohols / Primary alcohols / Organopnictogen compounds / Organonitrogen compounds / Organochlorides / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds show 2 more
- Substituents
- Benzenesulfonyl group / Sulfone / Sulfonyl / Carboxamide group / Secondary alcohol / Secondary carboxylic acid amide / Carboxylic acid derivative / Alcohol / Aromatic alcohol / Hydrocarbon derivative show 14 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- sulfone, monocarboxylic acid amide (CHEBI:32215)
Targets
- Kind
- Protein
- Organism
- Escherichia coli
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- Hemagglutinins of uropathogenic E.coli mediate adherence to the upper urinary tract. These adhesins bind to the Dr blood group antigen and also agglutinate human erythrocytes in the presence of D-m...
- Gene Name
- draA
- Uniprot ID
- P24093
- Uniprot Name
- Dr hemagglutinin structural subunit
- Molecular Weight
- 17058.095 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235]
Drug created on September 15, 2010 15:33 / Updated on November 02, 2018 06:51